Pharmadrug Inc.
LMLLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $18 | $75 | $75 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $18 | $16 | $9 | $23 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $5 | $26 | $49 |
| Total Curr. Assets | $30 | $39 | $110 | $147 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $527 | $540 | $552 | $565 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $527 | $540 | $552 | $565 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $557 | $578 | $662 | $712 |
| Liabilities | – | – | – | – |
| Payables | $0 | $518 | $622 | $370 |
| Short-Term Debt | $1,490 | $1,434 | $1,380 | $1,349 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $577 | $49 | $0 | $237 |
| Total Curr. Liab. | $2,067 | $2,001 | $2,001 | $1,956 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,067 | $2,001 | $2,001 | $1,956 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $34,015 | $34,015 | $34,015 | $33,990 |
| Retained Earnings | -$39,357 | -$39,280 | -$39,207 | -$39,107 |
| AOCI | -$30 | -$30 | -$31 | -$31 |
| Other Equity | $3,743 | $3,743 | $3,743 | $3,746 |
| Total Equity | -$1,630 | -$1,552 | -$1,481 | -$1,403 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $120 | $130 | $142 | $159 |
| Total Liab. & Tot. Equity | $557 | $578 | $662 | $712 |
| Net Debt | $1,484 | $1,416 | $1,305 | $1,274 |